Michel Jolivet
13Patents
4h-index
30Co-inventors
56Inventor score
Filing activity: Dec 11, 1985 → Feb 19, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4695562A | Synthetic peptide compounds | Human Necessities | 14 | Expired |
| US6890720B1 | Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis | Chemistry; Metallurgy | 11 | Expired |
| US6929918B1 | Method for diagnosing an adenocarcinoma or a benign prostate pathology | Physics | 6 | Expired |
| US6235284A | Synthetic polypeptides belonging to the hepatitis C virus (HCV) and which can be used especially for detecting the latter | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6372443B1 | Cassette for expressing a toxoplasma gondii P30 protein | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5820864A | Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease | Chemistry; Metallurgy | 3 | Expired |
| US6403103B1 | Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6933110B1 | Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease | Chemistry; Metallurgy | 1 | Expired |
| US6270767A | Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease | Chemistry; Metallurgy | 1 | Expired |
| US6576240B1 | Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection | Chemistry; Metallurgy | 0 | Expired |
| US6964852B2 | Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection | Chemistry; Metallurgy | 0 | Expired |
| US8241856B2 | Method for detecting rheumatoid arthritis-specific autoantibodies | Physics | 0 | Expired |
| US6602853B1 | Antigenic peptides reacting with anti-ovary antibodies | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.